Dow Up0.15% Nasdaq Up0.21%

Revance Therapeutics, Inc. (RVNC)

-NasdaqGM
21.58 0.69(3.30%) Sep 17, 4:00PM EDT
Insider TransactionsGet Insider Transactions for:
Net Share Purchase Activity
Insider Purchases - Last 6 Months
 SharesTrans
PurchasesN/AN/A
SalesN/AN/A
Net Shares Purchased
(Sold)
N/AN/A
Total Insider Shares HeldNaNN/A
% Net Shares Purchased
(Sold)
N/AN/A
Net Institutional Purchases - Prior Qtr to Latest Qtr
 Shares
Net Shares Purchased
(Sold)
N/A
% Change in Institutional Shares HeldN/A
Data provided by Thomson Financial


Insider Transactions Reported - Last Two Years
DateInsiderSharesTypeTransactionValue*
Sep 2, 2014BERTOLINO ARTHUR PETEROfficer39,375DirectAcquisition (Non Open Market) at $0 per share.N/A
Aug 18, 2014WAUGH JACOBOfficer25,000DirectSale at $24.47 per share.611,750
May 19, 2014RUEGG CURTISOfficer10,500DirectAcquisition (Non Open Market) at $32.22 per share.338,310
May 19, 2014WAUGH JACOBOfficer25,000DirectAcquisition (Non Open Market) at $32.22 per share.805,500
May 19, 2014BROWNE L DANIELOfficer96,000DirectAcquisition (Non Open Market) at $32.22 per share.3,093,120
May 19, 2014SILVERNAIL LAUREN POfficer14,000DirectAcquisition (Non Open Market) at $32.22 per share.451,080
Feb 11, 2014GLASHEEN JAMES WALTERDirector673,778IndirectAcquisition (Non Open Market) N/A
Feb 11, 2014GLASHEEN JAMES WALTERDirector52,236IndirectOption Exercise N/A
Feb 11, 2014TUNNICLIFFE JONATHANDirector2,697,933IndirectAcquisition (Non Open Market) N/A
Feb 11, 2014EASTMAN RONALD WDirector3,727,673IndirectAcquisition (Non Open Market) N/A
Feb 11, 2014EASTMAN RONALD WDirector407,289IndirectOption Exercise N/A
Feb 11, 2014TUNNICLIFFE JONATHANDirector398,717IndirectOption Exercise N/A
Feb 11, 2014WOOTEN RONALD JDirector2,697,933IndirectAcquisition (Non Open Market) N/A
Feb 11, 2014BROWNE L DANIELOfficer17,702IndirectAcquisition (Non Open Market) N/A
Feb 11, 2014WOOTEN RONALD JDirector398,717IndirectOption Exercise N/A
Feb 11, 2014GARDNER PHYLLISDirector444,246IndirectAcquisition (Non Open Market) N/A
Feb 11, 2014GARDNER PHYLLISDirector12,839IndirectOption Exercise N/A
Feb 11, 2014ESSEX WOODLANDS HEALTH VENTURES FUND VIII LPBeneficial Owner (10% or more)3,727,673IndirectAcquisition (Non Open Market) N/A
Feb 11, 2014ESSEX WOODLANDS HEALTH VENTURES FUND VIII LPBeneficial Owner (10% or more)407,289IndirectOption Exercise N/A
Feb 11, 2014NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P.Beneficial Owner (10% or more)2,697,933IndirectAcquisition (Non Open Market) N/A
Feb 11, 2014NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P.Beneficial Owner (10% or more)398,717IndirectOption Exercise N/A
Feb 5, 2014BROWNE L DANIELOfficer53,333DirectStatement of OwnershipN/A
Feb 5, 2014WAUGH JACOBOfficer53,333DirectStatement of OwnershipN/A
Feb 5, 2014RUEGG CURTISOfficer3,606DirectStatement of OwnershipN/A
Data provided by EDGAR Online
* = Where indicated, some values are estimates.
1= Potential proceeds estimated by the filer.
2= Estimated based on the average of multiple prices reported.
3= Multiple dates reported. Most recent date shown.

Currency in USD.



All Major Holders - Insider Roster